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Receptor for activated C kinase-2 (RACK2)
Golgi apparatus
Phorbol esterProtein kinase C epsilon (PKCε) contributes to multiple signaling pathways affecting human disease. The func-
tion of PKCε requires it to undergo changes in subcellular distribution in response to signaling events. While
themechanisms underlying this translocation are incompletely understood, it involves the receptor for activated
C kinase protein (RACK2/β′-COP). This receptor also functions as a vesicle coat protein in the secretory pathway
where it is regulated by the small GTP-binding protein ADP-ribosylation factor, ARF1. We inhibited ARF1 activa-
tion to test the requirement for RACK2/β′-COP in PKCε localization in NIH3T3 ﬁbroblasts. We found that
steady-state localization of PKCε at the Golgi complex requires ARF1-regulated RACK2/β′-COP function. By con-
trast, we did not observe any defects in phorbol ester-induced translocation when ARF1 was inhibited. We also
found that PKCε bound to isolated membranes through two distinct mechanisms. One mechanism was depen-
dent upon RACK2/β′-COP while a second was RACK2/β′-COP-independent and stimulated by phorbol esters.
Finally, we show that RACK2/β′-COP affects the subcellular distribution of a constitutively active form of PKCε,
in a manner similar to what we observed for wild-type PKCε. Together, our data support a role for RACK2/
β′-COP in the steady-state localization of PKCε at the Golgi apparatus, whichmay be independent of its role dur-
ing PKCε translocation to the cell surface.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Protein kinase C epsilon (PKCε) contributes to signal transduction
pathways that regulate a diverse range of cellular processes including
proliferation, differentiation, metabolism, and intracellular trafﬁcking
[1–3]. PKCε acts as an oncogene in vitro andmay serve as a tumor bio-
marker [4,5]. Signaling pathways that can protect heart cells from is-
chemic damage also rely on PKCε-mediated phosphorylation [6–8].
The contribution of PKCε to multiple signaling pathways and disease
states arises in part through its ability to localize to different sites
within the cell. Depending on the cell type and signaling state, PKCε
can adopt distinct subcellular localization, for example at the nucleus,
mitochondria, plasma membrane, Golgi apparatus or actin microﬁla-
ments [9–12]. Remarkably, PKCε distribution can change rapidly
during signal transduction. In heart cells, activation of adenosine re-
ceptors causes PKCε to redistribute to sarcomeres [8,13,14]. PKCε lo-
calizes to the Golgi apparatus in ﬁbroblasts, but rapidly dissociates
from the Golgi membrane and translocates to the cell surface orTA, [1,2,-bis(o-aminophenoxy)
; COP, coat protein; DMEM,
iculum; GFP, green ﬂuorescent
buffered saline; PKC, protein ki-
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nes).
rights reserved.nucleus when PKC-signaling is activated by addition of phorbol esters
[10,15–17].
The subcellular distribution and translocation of PKCε relies on
targeting motifs within its N-terminal regulatory domain. The epsilon
isoform belongs to the novel subclass of PKC that contains N-terminal
regulatory C2-like and C1 domains separated from the C-terminal ki-
nase domain by a hinge region [2]. The C1 domain binds diacylglycerol
and other lipids to affect activation and localization. The C1 domain is
also the binding site for carcinogenic phorbol esters that are potent ac-
tivators of the conventional and novel sub-types of PKC [3]. The C1 do-
mainmay also inﬂuence PKCε localization through protein interactions,
for example with the Golgi-apparatus cargo receptor protein, p23
[18,19]. C2 domains are a second major targeting motif shared by
many PKC isoforms. PKCε has a C2-like domain upstream of the C1 do-
main. Unlike conventional PKCs, the C2-domain of PKCε does not bind
calcium. The C2 domain confers binding to localization receptors called
RACKs (receptor of activated C kinase) [1–3,20]. Each PKC isoform binds
with unique afﬁnity to RACKs; PKCε binds preferentially to RACK2 or
εRACK [20]. The binding interaction between RACK2 and PKCε contrib-
utes to cardioprotective signal transduction [6–8,21,22]. Peptides that
inhibit the binding interaction between RACK2 and PKCε also inﬂuence
tumor cell growth [4,23].
Interestingly, RACK2 has been identiﬁed previously as the β′-COP
subunit of coatomer, a heteroheptameric transport vesicle coat com-
plex [20]. The coatomer complex is highly enriched on membranes
at the Golgi apparatus and the Golgi/ER-intermediate compartment
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Coatomer has been best characterized as the coat protein for COPI
vesicles that mediate transport within the Golgi complex and retro-
grade trafﬁcking from the Golgi to the endoplasmic reticulum [24].
The connection, if any, between RACK2/β′-COP function in vesicular
transport and in PKCε signal transduction is unclear.
The role for RACK2/β′-COP as a receptor that targets activated
PKCε is incompletely understood. The RACK2/β′-COP-PKCε binding
interaction is implicated in translocation to the cell surface in ﬁbro-
blasts. For example, peptides and point mutations predicted to pro-
mote the binding interaction with RACK2/β′-COP facilitate PKCε
translocation to the plasma membrane [17]. RACK2/β′-COP has also
been implicated in PKC localization to the Z disk on sarcomeres in
cardiomyocytes [8,11]. However, the coatomer complex including,
RACK2/β′-COP, is predominantly localized to the Golgi apparatus in
most cell types. This localization would seem more consistent with
a role for RACK2/β′-COP in the steady-state distribution of PKCε at
the juxtanuclear Golgi apparatus. We have now used PKCε distribu-
tion in cultured ﬁbroblasts and cell-free membrane binding assays
to better deﬁne the contribution of the RACK2/β′-COP subunit of
coatomer to PKCε localization and translocation.2. Materials and methods
2.1. Materials
The following antibodies were used in these studies: rabbit
anti-ε-COP [25], rabbit anti-PKCε C-15 (Santa Cruz Biotechnology,
Santa Cruz, California), and mouse anti-GM130 (BD Transduction
Laboratories, Franklin Lakes, New Jersey). TPA was obtained from
Cell Signaling Technology (Danvers, Massachusetts). Lipofectamine
2000 was obtained from Life Technologies (Carlsbad, California).
Brefeldin A and GTPγS were obtained from Sigma-Aldrich (St. Louis,
Missouri). Superdex 200 beads were obtained from GE Healthcare
Biosciences (Piscataway, NJ).2.2. Cell culture
NIH3T3 cellswere grownonglass cover slips inDMEMsupplemented
with 10% fetal calf serum, 100 U/ml penicillin-streptomycin, and
non-essential amino acids. Subconﬂuent cultures were transfected with
plasmids encoding GFP-PKCε, mCherry-PKCε, GFP-PKCε(Α159Ε), and/or
β′-COP-GFP as indicated in the ﬁgure legends using Lipofectamine
2000. For the translocation assay, NIH3T3 cells were treated with TPA
and/or brefeldin A (BFA) at the indicated concentrations and times. Con-
trol cells were treated with solvents, either DMSO or methanol alone. To
measure retrograde translocation, the media containing TPA was re-
moved after 10 min and replaced with fresh 37 °C DMEM, and the cells
were then incubated at 37 °C for the indicated times.2.3. Immunoﬂuorescence
The cells were washed with PBS and ﬁxed with 4% paraformalde-
hyde. They were quenched with 50 mM ammonium chloride for
10 min before permeabilization using 0.1% Triton X-100 for 4 min at
room temperature. The cells were washed three times with PBS and
blocked with 2% donkey serum in PBS at room temperature for
30 min. Appropriate dilutions of the primary antibodies in PBS plus
0.2% donkey serum and 0.1% Tween 20 were added to cells for 1 h
at room temperature. The cells were washed three times with PBS
and incubated with secondary antibodies. The cells were washed
again three times, mounted on slides, and analyzed by confocal mi-
croscopy (model LSM-510; Carl Zeiss MicroImaging, Thornwood,
New York).2.4. Membrane-binding assays
Rat-livermembranes and bovine-brain cytosol were prepared as de-
scribed previously [26,27]. For Fig. 6, coatomer-depleted cytosol was
prepared as described previously [28]. Brieﬂy, bovine brain cytosol
was fractionated by gel ﬁltration using Superdex 200 beads. The frac-
tions containing the high molecular weight coatomer complex were
identiﬁed byWestern blot analysis. The non-coatomer-containing frac-
tions were recombined and concentrated to generate depleted cytosol.
Intact cytosol was prepared by recombining and concentrating all of the
column fractions.
Themembranes and cytosolwere incubatedwith a ﬁnal reaction vol-
ume of 0.2 ml as described previously [29]. GTPγS and TPAwere includ-
ed in the reactions at the indicated concentrations. For the experiments
using BFA the membranes and cytosol were preincubated separately
such that the ﬁnal BFA concentration was 400 μM. Preincubation with
methanol alone (2% ﬁnal) was carried out as a control. Following the in-
cubation, the membranes were reisolated from the reaction by ﬂotation
through an isopycnic sucrose gradient [29]. Fractions were recovered
from the top and analyzed by Western blotting. Western blot signals
were quantiﬁed by densitometry and normalized to standard curves
generated from a serially diluted cytosol [30].
3. Results
3.1. Dissociation from Golgi membranes is not sufﬁcient for translocation
to the cell surface
NIH3T3 ﬁbroblasts provide a good model to study the molecular
mechanisms underlying PKCε localization and its regulation. In these
cells, the epsilon isoform localizes to the Golgi apparatus at steady state,
but undergoes nearly complete translocation to the plasma membrane
in response to PKC-activating phorbol-esters [15,16]. As expected,we ob-
served that the GFP-PKCε localized to the juxtanuclear Golgi apparatus at
steady state when expressed transiently in NIH3T3 cells (Fig. 1A). Fur-
thermore, we conﬁrmed that the GFP-PKCε undergoes rapid redistribu-
tion to the cell surface upon addition of the phorbol ester, TPA (Fig. 1A).
RACK2/β′-COP has been previously described as a receptor
directing PKCε translocation in response to cell signaling [17,31].
However, RACK2/β′-COP localizes to the Golgi apparatus as part of
the coatomer transport-vesicle-coat complex and could also contrib-
ute to steady-state PKCε localization. Coatomer localization to the
Golgi apparatus requires activation of the small GTP-binding protein
ARF1 [32]. We tested whether RACK2/β′-COP, as part of the coatomer
complex, contributes to PKCε steady-state localization by treating the
GFP-PKCε-expressing cells with BFA (Fig. 1B). BFA inhibits nucleotide
exchange on ARF1 causing both ARF1 and coatomer to rapidly disso-
ciate from the Golgi membranes [33]. We used a relatively low BFA
concentration (10 μM) and short time point (15 min.) that dissociat-
ed ARF1 and coatomer from the membrane yet caused only modest
disruption of Golgi morphology. Following BFA treatment, GFP-PKCε
no longer localized to the Golgi apparatus and appeared dispersed
throughout the cytoplasm (Fig. 1B). GFP-PKCε did not appear
enriched at the plasma membrane in the presence of BFA alone, indi-
cating that dissociation from the Golgi apparatus is not sufﬁcient for
redistribution to the plasma membrane. The effects of BFA indicate
that PKCε localization in cells can be regulated by ARF-family
GTP-binding proteins. Furthermore, it suggests that the interaction
between PKCε and the RACK2/β′-COP subunit of coatomer can con-
tribute to the steady-state localization of PKCε at the Golgi apparatus.
3.2. ARF-regulated coatomer function is not required for PKCε binding
and dissociation from the plasma membrane
RACK2/β′-COP is implicated as a receptor that promotes transloca-
tion of PKCε upon activation [15,16]. We tested the contribution of
Fig. 1. The localization of PKCε at the Golgi apparatus is sensitive to the ARF1 inhibitor, BFA. NIH3T3 ﬁbroblast cells were transfected with GFP-PKCε (green). (A) Cells were treated
for 10 min with DMSO (control) or with 100 nM of the phorbol ester, TPA. (B) Cells were treated for 15 min with methanol (MeOH) as a control or with 10 μM brefeldin A (BFA).
Cells were ﬁxed and stained for GM130 (red). Images were taken using a confocal electron micrograph. Representative images are shown for experiments that were repeated at
least three times with similar results. The size bar corresponds to 10 μm.
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prior to activation with the phorbol ester, TPA. As expected, when the
cells were treated with TPA in the absence of BFA, the GFP-PKCε
redistributed and within 10 min was found almost exclusively at
the plasma membrane (Fig. 2A). In the presence of BFA, we observed
that PKCε was dispersed throughout the cell consistent with the pre-
vious experiment. Nevertheless, the BFA-dispersed GFP-PKCε rapidly
translocated to the cell surface within 10 min of TPA addition
(Fig. 2A). This indicates that that ARF1-regulated coatomer functionFig. 2. ARF-regulated coatomer function is not required for the translocation to or dissoc
with GFP-PKCε (green). (A) Cells were ﬁrst treated with MeOH (control) or 50 μM BFA fo
TPA. (B) Retrograde translocation of PKCε. Cells were treated for 10 min with TPA, follow
with TPA followed by a 2-hour TPA washout containing DMSO (control) or 50 μM BFA. Ce
Images were taken using a confocal electron micrograph. Representative images are shown
bar corresponds to 10 μm.is not essential for PKCε translocation to the cell surface. Together,
the effects of BFA support a role for RACK2/β′-COP in the
steady-state localization of PKCε at the Golgi apparatus.
PKCε translocation in response to cell signaling has predominantly
been studied in the “anterograde” direction—from the Golgi appara-
tus to the cell surface. It is also possible that RACK2/β′-COP plays a
role during “retrograde” translocation from the cell surface back to
the Golgi apparatus. We tested this by treating cells with TPA for
10 min and then examining PKCε distribution after removing theiation of PKCε from the plasma membrane. NIH3T3 ﬁbroblast cells were transfected
r 30 min followed by a 10 min treatment with DMSO (control) or the phorbol ester,
ed by a TPA washout for the indicated time points. (C) Cells were treated for 10 min
lls from A, B, and C were ﬁxed at indicated time points and stained for GM130 (red).
for experiments that were repeated at least three times with similar results. The size
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washout, PKCε is found to have mostly dissociated from the plasma
membrane within 1 h and is mostly localized to the Golgi apparatus
within 2 h. The slow kinetics of PKCε redistribution to the Golgi appa-
ratus is consistent with previous reports analyzing the consequences
of washing out phorbol esters and may reﬂect slow turnover of TPA
[34]. Treating cells with a relatively high concentration of BFA
(50 μM) before and during the TPA washout had no overt effect on
the dissociation of PKCε from the cell surface (Fig. 2C). As expected,
in the presence of BFA, the PKCε did not relocalize to the juxtanuclear
region following the washout but stayed dispersed in the cytosol. The
effects of BFA during “retrograde” translocation indicate that the
ARF-regulated coatomer complex does not play an essential role in
the dissociation reaction at the plasma membrane. ARF1 function
was necessary for correct Golgi morphology and the juxtanuclear
steady-state distribution of PKCε.3.3. PKC activation does not cause overt redistribution of coatomer
Our data support the model that coatomer contributes to PKCε
localization in NIH3T3 ﬁbroblasts. As an additional test of RACK2/
β′-COP's role during signal-induced PKCε translocation, we com-
pared the distribution of RACK2/β′-COP-GFP and mCherry-PKCε in
cotransfected NIH3T3 cells before and after TPA treatment (Fig. 3).
At steady state, both proteins colocalized at the juxtanuclear Golgi ap-
paratus. While the mCherry-PKCε rapidly dissociated from the Golgi
apparatus and translocated to the plasma membrane after TPAFig. 3. PKCε activation does not cause overt redistribution of coatomer. NIH3T3 ﬁbro-
blast cells were co-transfected with mCherry-PKCε (red) and β′-COP-GFP (green).
Cells were treated 10 min with DMSO (control) or 100 nM of the phorbol ester, TPA.
Following the 10 min treatment, cells were ﬁxed and stained for GM130 (blue). Images
were taken using a confocal electron micrograph. Representative images are shown for
experiments that were repeated at least three times with similar results. The size bar
corresponds to 10 μm.addition, there was no overt change in RACK2/β′-COP-GFP distribu-
tion. This experiment does not exclude the possibility that a small
fraction of the total cellular coatomer redistributes and contributes
to PKCε translocation. However, it indicates that TPA-induced trans-
location of PKCε does not involve a dramatic redistribution of the
coatomer complex or of the RACK2/β′-COP subunit alone.
3.4. PKCε can bind isolated membranes through both coatomer-dependent
and -independent mechanisms
The analysis of PKCε translocation in ﬁbroblasts suggests that PKCε
can form distinct binding interactions with intracellular membranes.
The steady-state localization at the Golgi apparatus appears to require
a binding interactionwith the ARF1-regulated pool of coatomer. By con-
trast translocation and localization at the plasma membrane appear to
be independent of the bulk of cell coatomer. One possibility is that
there is an ARF1-coatomer-dependent binding interaction with Golgi
membranes at steady state, and an ARF1-coatomer-independent reac-
tion at the plasma membrane upon activation with phorbol esters. We
further characterized the requirements for coatomer during PKCε bind-
ing interactions with membranes using cell-free assays (Fig. 4). Brieﬂy,
a membrane preparation was incubated with cytosol, and then
reisolated away from the reaction by isopycnic centrifugation [29].
Membrane-bound proteins were then quantiﬁed by Western blotting.
We found that both GTPγS, a non-hydrolyzable GTP analog, and
TPA stimulated PKCε binding to membranes in vitro (Fig. 4A and B).
We conﬁrmed that GTPγS activates ARF1-dependent coatomer bind-
ing in vitro, however, we did not observe an increase in coatomer
binding in the presence of TPA (Fig. 4C). The fact that coatomer and
PKCε binding are correlated upon addition of GTPγS, but not TPA, in-
dicates that GTPγS- but not TPA-dependent PKCε binding to mem-
branes is mediated by coatomer. We tested this possibility by
examining the effects of inhibiting ARF1 and coatomer binding with
BFA. We found that the GTPγS-activated binding of PKCε was
inhibited by BFA whereas the TPA-dependent binding was unaffected
by BFA (Fig. 4A and B).
Others and we showed previously that the calcium chelator BAPTA
causes coatomer to dissociate frommembranes both in cell-free binding
assays and within intact cells [35,36]. Hence, we determined whether
BAPTA affected PKC binding. As with BFA, we found that BAPTA
inhibited the GTPγS-activated PKCε binding to membranes but not
the TPA-activated binding (Fig. 4D). The results with BFA and BAPTA
support a role for coatomer in GTPγS-stimulated, but not TPA stimulat-
ed PKCε binding to membranes. Nevertheless, BFA and calcium chela-
tors could affect PKCε binding by disrupting factors other than ARF1
and coatomer. To address this, we have examined the ability of PKCε
to bind membranes from cytosol that had been depleted of the
high-molecular-weight coatomer complex. Intact cytosol supported
both TPA and GTPγS-dependent binding whereas the coatomer-
depleted cytosol supported TPA-dependent, but not GTPγS-dependent
binding (Fig. 5). Upon quantifying and averaging three experiments,
we found that GTPγS stimulated PKCε binding 7.6 fold in intact cytosol
but only 2.6 fold with depleted cytosol. By contrast, TPA stimulated
binding to a similar extent in intact and depleted cytosol, 10.8 and 9.7
fold respectively.
Our results using the binding assay support themodel that PKCε can
interactwithmembranes through two distinctmechanisms. Onemech-
anism is dependent on the previously characterized targeting receptor
RACK2/β′-COP, functioning as part of the ARF1-regulated coatomer
complex. A second membrane binding mechanism is independent of
RACK2/β′-COP and can be stimulated by TPA.
3.5. Coatomer can inﬂuence localization of kinase-active PKCε
Somemodels for PKC signaling suggest that the kinase is stored at one
site in the cell as an inactive poolwhich thenundergoes translocation to a
Fig. 4. PKCε binds isolated membranes through coatomer-dependent and -independent mechanisms. Cell-free membrane binding assays were conducted as described in the
Materials and methods. The levels of membrane bound PKCε was determined following incubations with and without GTPγS (A) or TPA (B) in the absence or presence of BFA.
(C) Plotted is the average level of membrane bound ε-COP treated with vehicle, GTPyS, or TPA in the absence or presence of BFA. (D) The level of membrane bound PKCε was de-
termined following incubations containing vehicle, GTPyS, or TPA in the absence or presence of BAPTA. Plotted are the average levels from three independent experiments. Bars
indicate the standard error.
491T.A. Peterson, M. Stamnes / Biochimica et Biophysica Acta 1833 (2013) 487–493new site following activation [2,37]. RACKs, deﬁned as receptors for
“active” C kinase, are anticipated to participate in the targeting or trans-
location of the active PKC pool. Indeed, RACK2/β′-COP is implicated
in the translocation and targeting of active PKCε in ﬁbroblasts andFig. 5. Coatomer-depleted cytosol supports TPA-dependent, but not GTPγS-dependent,
binding of PKCε to membranes. Cell-free assays were carried out as described in the
Materials and methods with intact or coatomer-depleted cytosol. GTPγS, TPA, or vehi-
cle was added as indicated. The experiment was repeated three times with similar re-
sults. Shown is a representative Western blot probed with anti-PKCε and anti-ε-COP
antibodies.cardiomyocytes [7,8,17,20,22,37]. In this regard, we were interested in
whether RACK2/β′-COP as part of the coatomer complex only binds an
inactive pool of PKCε stored at the Golgi apparatus, or whether it also in-
teracts with active PKCε. A constitutively active mutant form of
PKCε(A159E) was shown previously to localize to the Golgi apparatus
[15]. We treated GFP-PKCε(A159E)-expressing ﬁbroblasts with BFA to
determine whether the Golgi localization of active PKCεwas dependent
on ARF1-regulated coatomer. Similar to the wild-type PKCε (Fig. 1),
GFP-PKCε(A159E)was found to dissociate from theGolgi apparatuswith-
in 15 min after BFA addition (Fig. 6A). Interestingly, GFP-PKCε(A159E)
still undergoes translocation to the cell surface in response to TPA both
in the presence and absence of BFA (Fig. 6B). This result indicates that
TPA-induced translocation involves mechanisms that are independent
of the binding interaction with coatomer and activation of the kinase
domain.
Our data, using isolatedmembranes and using intact cells, support a
model with multiple membrane receptors required for PKCε targeting
and translocation. The RACK2/β′-COP contributes most signiﬁcantly to
Golgi localization in ﬁbroblasts, whereas phorbol-ester-induced bind-
ing to the plasma membrane may rely more extensively on a RACK2/
β′-COP-independent receptor. Our results indicate that PKCε could in
principle exist in a kinase-active form not only at the cell surface but
also complexed with coatomer at the Golgi apparatus.
Fig. 6. ARF-regulated coatomer contributes to the localization of constitutively active
PKCε. NIH3T3 ﬁbroblast cells were transfected with GFP-PKCε(A159E) (green). (A) Cells
were treated for 15 min with MeOH (control) or 10 μM brefeldin A (BFA). (B) Cells
were ﬁrst treated with MeOH (control) or 50 μM BFA for 30 min followed by a 10 min
treatmentwith thephorbol ester, TPA. Cellswereﬁxed and stained for theGolgi apparatus
marker GM130 (red). Representative confocal micrographs are shown for three indepen-
dent experiments. The size bar corresponds to 10 μm.
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PKCε has many cell-type- and context-speciﬁc signaling roles that
include contributions to alcohol-addictive behavior, insulin secretion,
cardioprotective signal transduction, and cell growth [3,6,8,15,38,39].
In order to play diverse roles, PKCε must respond to multiple up-
stream activating signals, phosphorylate multiple substrates, and lo-
calize to multiple sites within the cell [2]. This is accomplished in
part by the ability of PKC family members to form context-speciﬁc
binding interactions with proteins and second messengers. Many of
these binding events are directed through speciﬁc motifs in the
N-terminal regulatory domains (C1 and C2) of PKCε.
Unlike conventional PKCs where the C2 domain is critical as a calci-
um sensor, the most important role for the C2-like domain of the novel
PKCs such as PKCεmay be to bind to the RACKs [2]. The binding interac-
tion between PKCε C2 domain and RACK2/β′-COP has been implicated
in many PKCε-dependent signaling processes [4,6–8,21–23]. Indeed,
the isotype-speciﬁc inhibitors and stimulators of PKCε function ostensi-
bly by modulating the PKCε/RACK2-binding interaction [31]. The
identiﬁcation of a RACK for PKCε that had also been extensively charac-
terized as a transport vesicle coat protein at the Golgi apparatus was
surprising. The relationship between β′-COP's role in trafﬁcking and in
PKCε signaling is still not clear. Given that coatomer is enriched at the
Golgi apparatus, one would expect that coatomer contributes to PKCε
localization in the juxtanuclear/Golgi apparatus region as is observed
at steady state in ﬁbroblasts. However, multiple studies implicate the
β′-COP binding interaction in translocation to sites where coatomerwould not necessarily be enriched such as the plasma membrane and
muscle sarcomeres [8,14,17,31].
The goal of this study was to determine how the binding interac-
tion between PKCε and RACK2/β′-COP contributes to localization
and translocation during signal transduction.
For the case of PKCε distribution in ﬁbroblasts, our results support a
role for coatomer in the steady-state localization of PKCε at the Golgi
apparatus, rather than a direct role in the translocation to the cell sur-
face. Speciﬁcally, we found that acute disruption of ARF1-regulated
coatomer in intact ﬁbroblasts caused PKCε to dissociate from themem-
branes while having little effect on phorbol-ester-induced translocation
to the cell surface. This interpretation is corroborated by our ﬁnding
that while PKCε can be recruited to isolated membranes in a
coatomer-dependent manner with GTPγS, phorbol-ester-dependent
binding appeared to be coatomer independent.
We cannot rule out from our intact-cell data that coatomer con-
tributes to both Golgi localization and translocation to the cell surface.
For instance, a minor pool of RACK2/β′-COP, not obvious by ﬂuores-
cence microscopy and independent of ARF regulation, could function
directly as a RACK for translocation to the cell surface. It could also be
that Golgi localized RACK2/β′-COP inﬂuences post-translational mod-
iﬁcations on PKCε such as phosphorylation or nitration that subse-
quently affect intracellular distribution. Nevertheless, the intact cell
data, when taken together with our demonstration of RACK2/
β′-COP-independent membrane binding induced by TPA, indicate
that the most parsimonious interpretation of our results is that
RACK2/β′-COP serves as a RACK for targeting PKCε to the Golgi appa-
ratus while there are separate targeting mechanisms that are respon-
sible for enrichment at the plasma membrane.
Many binding interactions with PKCε have been previously de-
scribed that could mediate the RACK2/β′-COP-independent binding.
For example, binding interactions between the C1 domain and mem-
brane diacylglycerol also play a central role in PKCε distribution and
activation [2,3]. PKCε is unique among PKC isoforms in that it has a
short actin-binding motif within the C1 domain [2,40]. Other integral
membrane proteins such as the putative cargo receptor p23 also bind
to the C1 domain [18,19]. PKCε can be targeted to caveolae at the cell
surface [41]. Finally, a large repertoire of signaling molecules, for ex-
ample PDLIM5, TRAM, and the 14-3-3 protein bind and affect the ac-
tivity of PKCε [2].
As our study was restricted to a ﬁbroblast cell line, it must be
noted that RACK2/β′-COP could serve as a RACK for targeting to
sites other than the Golgi apparatus in different cell types. For exam-
ple, RACK2/β′-COP was shown to localize to sarcomeric myoﬁbrils in
cardiomyocytes [8,14]. PKCε was recruited to the RACK2/β′-COP on
sarcomeres upon activation of adenosine receptor signaling. Our ﬁnd-
ing that coatomer contributes to the localization of a kinase-active
mutant form of PKCε also supports the model that the binding inter-
action with RACK2/β′-COP contributes not just to a storage pool but
also to the subcellular distribution of PKCε following its activation
through signaling cascades. It will be important to test independently
the role of coatomer both at steady state and during signal-dependent
translocation of PKCε in specialized cells such as tumor-derived cells
and myocytes.
To summarize, our results indicate that PKCε localization and trans-
locationmay rely onmultiple RACKs and targeting signals. Further stud-
ies will be necessary to deﬁne all of the multiple protein–protein
binding interactions that specify the distribution and translocation of
PKCε during signal transduction. This knowledge will advance our un-
derstanding of the contribution of PKCε to many human diseases in-
cluding diabetes, cancer, and cardioprotective signal transduction.
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